Companies Dominating the Interstitial Cystitis Drug Landscape
- Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Johnson & Johnson
- Kyorin Pharmaceutical Co Ltd.
- UCB Pharma
- Bayer AG
- Eli Lilly and Company
- Lipella Pharmaceuticals
- Seikagaku Corporation
- Grünenthal
Browse Key Market Insights with Data Illustration:
In the News
- The Ministry of Health, Labor and Welfare granted Kyorin Pharmaceutical Co., Ltd. a license. marketing “Zymso 50% Intravenous Solution” for interstitial cystitis in Japan. Kyorin Pharmaceutical Company Limited is a wholly owned subsidiary of KYORIN Holdings, Inc.
- Kyorin Pharmaceutical Company Limited a wholly owned subsidiary of KYORIN Holdings, Inc., has launched the interstitial cystitis product "Zymso® Intravesical Solution 50%"
